We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Novacyt S.a. | LSE:NCYT | London | Ordinary Share | FR0010397232 | EUR1/15TH (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.60 | 8.70% | 70.00 | 70.00 | 72.60 | 73.80 | 63.00 | 63.00 | 404,034 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
In Vitro,in Vivo Diagnostics | 22.49M | -25.73M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
28/2/2021 22:20 | Likya123 - Odx tests for antibodies only. These tell you if you have had the virus in the past not if you are presently infected. NCYT has both, very accurate and cost saving. | fuji99 | |
28/2/2021 22:18 | Out of curiosity, what are the revenues/ profits for Omega?How many countries does it supply to & how many governments are involved? | investographer | |
28/2/2021 20:33 | Former French Health Director (William Dab) on BFM (French TV tonight)- the only solution to get away with this: strict lockdown (several weeks) to curb the epidemic then to deconfinement: test, trace, isolate.... as in China.... CQFD- In the short term, the vaccine is not a means of controlling the epidemic...vaccinate | routy | |
28/2/2021 20:09 | Government scaling down labs and pushing LFT's. Novacyt will struggle to maintain revenue streams from here. Best to reinvest in Omega. | likya123 | |
28/2/2021 20:08 | For those that have seen mass testing from car parks around the country they will now get used to seeing surge testing. Then they will have to change their mindset..infections are going down as novacyts clinical testing is rising. | bobdown2 | |
28/2/2021 20:00 | The available vaccins do not protect enough against the Brazilian variant that reached Europe and the UK. Sequencing will therefore be the next challenge all over the world. With its advanced test platforms, NCYT can help in identifying the new variants. So in addition to its own testing. NCYT will help in detecting new mutations for every positive test found elsewhere by other companies. | fuji99 | |
28/2/2021 19:43 | They also have 550 different tests From animals to agriculture A truly awe inspiring company. And last weeks webinar show the respect they are gaining in the markets that they are involved in.. | bobdown2 | |
28/2/2021 19:38 | Novacyt do a two gene test for the french market And can test for all the new variants. | bobdown2 | |
28/2/2021 19:30 | No, Novacyt's test doesn't do gene sequencing. | pastiche21 | |
28/2/2021 19:17 | Ps. Filter and post normally. | bobdown2 | |
28/2/2021 19:16 | We move into the second third of the first half tomorrow. Why does it take so long to get these results rns.d Can an update for the second half be issued before the final results.?? Due to the non disclosure clauses and the use of financial derivatives surely 5 months is an excessive amount of time to not know how your company finances were five months previous. Just having a whinge as two months wait looks more than enough. | bobdown2 | |
28/2/2021 18:26 | Brazil variant 'of concern' now discovered in UK.From BBC website "Public health officials are investigating the six cases and are deploying more testing to see if it has spread to more people. Some variants, like this one, appear to be more contagious and there are concerns vaccines may not work quite so well against them."More surge testing will be needed.Test Test Test | routy | |
28/2/2021 18:04 | Novacyt's existing polymerase chain reaction (PCR) COVID-19 portfolio remains highly accurate in detecting all published SARS-CoV-2 variants. The launch of the new SNPsig® portfolio complements and expands the Company's offering into the rapidly evolving requirement for PCR genotyping of variants. | dazzerman4 | |
28/2/2021 18:02 | Https://www.itv.com/ | dazzerman4 | |
28/2/2021 18:01 | Https://news.sky.com | dazzerman4 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions